P

Inventor

GEHRMANN MATHIAS

DE9 patents
⚠️ This page may combine multiple inventors who share the name “GEHRMANN MATHIAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MYRIAD INT GMBH

3 patents
US11913078B2Feb 27, 2024

Method for breast cancer recurrence prediction under endocrine treatment

MYRIAD INT GMBH0 citations53
US10851427B2Dec 1, 2020

Method for breast cancer recurrence prediction under endocrine treatment

MYRIAD INT GMBH0 citations43
US10577661B2Mar 3, 2020

Method for breast cancer recurrence prediction under endocrine treatment

MYRIAD INT GMBH0 citations43

SIEMENS HEALTHCARE DIAGNOSTICS

2 patents
US7541149B1Jun 2, 2009

Monoclonal antibody and assay for detecting PIIINP

SIEMENS HEALTHCARE DIAGNOSTICS2 citations60
US7668661B2Feb 23, 2010

Liver disease-related methods and systems

SIEMENS HEALTHCARE DIAGNOSTICS3 citations58

BEHRINGWERKE AG

1 patent
US7060495B2Jun 13, 2006

Fusion proteins for prodrug activation

BEHRINGWERKE AG30 citations92

VOLKER MICHAEL

1 patent
US7141380B2Nov 28, 2006

Assessment of liver fibrosis scoring with serum marker algorithms

VOLKER MICHAEL10 citations64

BEHRINWERKE AG

1 patent
US7273727B2Sep 25, 2007

Fusion proteins for prodrug activation

BEHRINWERKE AG1 citations44

SIVIDON DIAGNOSTICS GMBH

1 patent
US10301685B2May 28, 2019

Method for predicting the benefit from inclusion of taxane in a chemotherapy regimen in patients with breast cancer

SIVIDON DIAGNOSTICS GMBH0 citations35